ZELBORAF (vemurafenib) tablet. FDA-Approved

ZELBORAF (vemurafenib) tablet can be ordered by patient or doctor, if the drug has not been approved or is not available in your country. Medvitaz Pharma Solutions can help you from India to get best price/cost of ZELBORAF (vemurafenib) tablet to treat adults with melanoma.
Categories: , .

ZELBORAF (vemurafenib) tablet. FDA-Approved

What is FDA-approved ZELBORAF (vemurafenib) tablet indicated for?

ZELBORAF (vemurafenib) tablet is a prescription medicine. ZELBORAF (vemurafenib) tablet is used to treat adults with unresectable or metastatic melanoma.
INDICATIONS AND USAGE
ZELBORAF is a kinase inhibitor indicated for the treatment of patients with unresectable or metastatic melanoma with BRAF V600E mutation as detected by an FDA-approved test.
DOSAGE FORMS & STRENGTHS Tablet: 240 mg
Manufactured By: Genentech
Prescribing Information URL: Click Here

How to make an enquiry for ZELBORAF (vemurafenib) tablet?

Anticancer medicine ZELBORAF (vemurafenib) tablet available upon request. To get best price in india, Call 9811747774 or Email info@medvitaz.com to discuss advanced treatments with Breast Cancer Specialists in India without travel. Medvitaz Pharma Solutions can help you to get genuine, affordable and assurance of delivery of approved medicines for Blood Cancer.

What Vemurafenib is indicated for?

Vemurafenib (INN, marketed as Zelboraf) is an inhibitor of the B-Raf enzyme developed by Plexxikon (now part of Daiichi-Sankyo) and Genentech for the treatment of late-stage melanoma. The name "vemurafenib" comes from V600E mutated BRAF inhibition.

Vemurafenib received FDA approval for the treatment of late-stage melanoma on August 17, 2011, making it the first drug designed using fragment-based lead discovery to gain regulatory approval.

Vemurafenib later received Health Canada approval on February 15, 2012.

On February 20, 2012, the European Commission approved vemurafenib as a monotherapy for the treatment of adult patients with BRAF V600E mutation positive unresectable or metastatic melanoma, the most aggressive form of skin cancer.

On November 6, 2017, the FDA approved Vemurafenib for the treatment of some patients with Erdheim–Chester disease (ECD), a rare type of histiocytic neoplasm.

How and where to buy ZELBORAF (vemurafenib) tablet?

You can order ZELBORAF (vemurafenib) tablet from Medvitaz Pharma Solutions if the drug has not been approved or is not available in your country. We help you to get genuine, affordable and assurance of delivery of approved medicines for Blood Cancer. To get best price/cost of ZELBORAF (vemurafenib) tablet in India, Call 8750295029 or Email urgent@medvitaz.com. FDA approved drugs of Australia, Canada, Delhi, EU, India, New Zealand, Singapore, Switzerland, Turkey & USA.

42 reviews for ZELBORAF (vemurafenib) tablet. FDA-Approved

Maryanego
Jasonanego
Amyanego
Judyanego
homepage

Great weblog here! Also your web site so much up fast! What web host are you using? Can I am getting your affiliate hyperlink to your host? I wish my web site loaded up as fast as yours lol.

https://1xbet-es.xyz/fr/

Judyanego
Denanego
Carlanego
Jasonanego
Eyeanego
Lisaanego
Kiaanego
Judyanego
Carlanego
Markanego
Alananego
Paulanego
Maryanego
Eyeanego
Jasonanego
Carlanego
Lisaanego
Amyanego
Paulanego
Amyanego
Amyanego
Alananego
Denanego
Ryhcgb

cialis 20 mg buy online uk – tadalafil india buy online tadalafil

Judyanego
Markanego
Mekeyy

generic female viagra 100mg – where to buy viagra in south africa sildenafil prescription medicine

Eyeanego
Alananego
Maryanego
Judyanego
Amyanego
Markanego
Maryanego
Denanego
Lisaanego
Carlanego

Add a review

neeraj
Neeraj Nagpal

Head of Operations

 The profound knowledge of more than 20 years in sales and marketing sector, he has been working dedicatedly and contributing to pharmaceuticals industry. He handles all operations over the country.

Contact Our Team

Contact us and we will reply as soon as possible!

    need help?

     MEDVITAZ is an initiative for helping end-users directly to get the right medicines and right medical treatments from the right source.